NasdaqGS:OMCLMedical Equipment
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors?
Omnicell has recently accelerated its shift from hardware-focused sales toward software and services, including acquiring ANiGENT in October 2025 to broaden its drug diversion detection capabilities and recurring revenue base.
This pivot toward subscription-like revenue streams is prompting investors to reassess Omnicell less as a traditional equipment maker and more as a healthcare IT provider, with different expectations for growth, risk and valuation.
Next, we’ll examine how Omnicell’s...